Multimodal Clinical Imaging Assessment of the Outcome in Mild-to-Moderate Acne: A Prospective Study

Kyrgidis, Athanassios; Becker, Markus; Zampeli, Vasiliki; Fauger, Aurélie; Sayag, Michèle; Zouboulis, Christos C.

doi:10.1159/000501272

Cited by 3 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CADI has been used in 13 studies 30,31,[41][42][43][44][45][46][47][48][49][50][51] describing pharmacological topical interventions (Table 2). The studies investigated the use of topical nadifloxacin and benzoyl peroxide, clindamycin and benzoyl peroxide, combined retinaldehyde and glycolic acid cream, adapalene and benzoyl peroxide, erythromycin and zinc acetate and several dermocosmetic products.…”

Section: Topical Drug Interventionsmentioning

confidence: 99%

See 1 more Smart Citation

Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI)*

et al. 2021

View full text Add to dashboard Cite

The Cardiff Acne Disability Index (CADI) is a questionnaire designed to measure the quality of life of teenagers and young adults with acne. It has been used clinically and within therapeutic research globally. This review aims to appraise all published data regarding the clinical and research experience of the CADI, its psychometric properties and validation, from its publication in 1992 until September 2020, in a single reference source. A literature search was conducted using MEDLINE via Ovid, PubMed, EBSCOhost, Web of Science and Scopus. All full articles in the English language were included. A total of 96 clinical studies were identified and analysed. The CADI has been used in 44 different countries, including four multinational studies, and has validated translations in 25 languages. Overall, 29 therapeutic interventions have used the CADI, demonstrating its responsiveness to change. The reliability of the CADI has been assessed in 14 studies through test-retest and internal consistency studies. In total, 57 studies have demonstrated aspects of its validity through correlation to other measures, and five studies have investigated the dimensionality of the CADI. There is evidence of high internal consistency, test-retest reliability, responsiveness to change and significant correlation with other objective measures. The minimal clinically important difference and validated score meaning bands have not yet been reported. This information is needed to improve the interpretability of CADI scores for clinical use and in research. The authors of the CADI have also rephrased Question 2 of the measure to ensure inclusivity.What is already known about this topic?• Acne significantly impacts quality of life in patients.• There are several skin-specific and acne-specific instruments used in day-to-day practice and research.• The validation and other measurement properties of the Cardiff Acne Disability Index (CADI) have not been easily accessible.What does this study add?• The CADI has been extensively used and is a reliable and valid tool.• There is a need to develop validated CADI score bands and calculate the minimal clinically important difference.• The CADI authors have rephrased Question 2 to ensure that the wording is inclusive.• There is inconsistent reporting of CADI data and a need for guidelines when reporting and publishing quality-of-life data.

show abstract

Section: Topical Drug Interventionsmentioning

confidence: 99%

“…30,31,42,43,[45][46][47][49][50][51] One study 48 reported the percentage improvement and two studies gave a descriptive account of QoL improvement. 41,44 All 14 studies depicted improvement in CADI scores following intervention; however statistical significance was not always reported.…”

Section: Topical Drug Interventionsmentioning

confidence: 99%